Navigation Links
Use of Technology to Document Comorbid Conditions May Improve Reimbursement, Increase Documentation Accuracy Study Confirms

MOBILE, Ala., Oct. 10 /PRNewswire/ -- Major financial implications are at stake if healthcare facilities and physicians do not accurately record the health conditions of patients that are present on admission (POA), according to new regulations by the Centers for Medicare and Medicaid Services (CMS).

CMS is adjusting the logic for Diagnosis Related Group (DRG) assignment, including new methods for identifying patients who are severely ill (that is, have comorbid illnesses) and consequently warrant higher hospital reimbursement. To quality for this level of reimbursement, these secondary medical conditions must be identified and described in detail on the medical chart.

Recently-published research in the September 2007 Journal of Clinical Outcomes Management showed that concurrent coding utilizing electronic medical record technology can significantly increase the identification and documentation of these comorbid illnesses, which in turn increases the severity of illness and risk of mortality indexes used for reimbursement. The research, titled "Effect of Concurrent Computerized Documentation of Comorbid Conditions on the Risk of Mortality Index", partially relied on coding technology from DocuSys, Inc., a leading anesthesia information management system (AIMS) and medication management system provider.

"The technology provided by DocuSys provides a detailed view of comorbid conditions currently not available with common paper documentation in use by most anesthesia clinicians," said Dr. Jerry Stonemetz, Clinical Associate and Compliance Officer, Anesthesia & Critical Care Medicine, Johns Hopkins University. "This detail could significantly affect the data captured by most hospitals, resulting in improved reporting and documentation of comorbid conditions required by CMS and other organizations for reimbursement."

Documentation of comorbid conditions is a primary element of the DocuSys coding module, which is an embedded component of the company's AIMS application. This technology was developed specifically for anesthesiologists who traditionally see a large subset of hospital inpatients with varied medical conditions. It precisely captures a patient's existing medical conditions while assigning ICD-9 diagnosis codes to them. In the study, concurrent coding using this technology increased severity of illness and risk of mortality ratings by 16 percent and 17 percent respectively.

Accurate identification of comorbid conditions has been a challenge for healthcare providers that has only been recently addressed with technology, according to Dr. Peter Pronovost, Professor and Medical Director of the Center for Innovations in Quality Patient Care at Johns Hopkins Medical Institute and University School of Medicine. "Documenting comorbid conditions and consistent use of that data among healthcare providers has been challenging," he said. "Technological solutions to assist with identification of comorbidity have numerous benefits that include developing medical care plans specific to each patient which improves the probability of receiving correct payment from CMS. Also, with patient safety and quality measure reporting currently at the forefront of the healthcare industry, precise documentation of each case has never been more important."

About DocuSys

DocuSys is a market-leading anesthesia information management system (AIMS) and medication management system provider, maximizing both the quality of care and return on investment in surgery. The system incorporates customizable decision support, professional fee capture, comorbid condition documentation and an intravenous medication management application, which uses barcoding and digital imaging to automate documentation, tracking and billing of medication. DocuSys' modular design permits integration with existing hospital information systems, electronic drug dispensing cabinets, infusion pumps, physiologic monitors and other systems in those settings where intravenous medication delivery is key.

Contact: Tom Mitchell, Director of Marketing Communications


phone: (251) 461-9903, ext. 133

Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Vedic vibration technology- the new cure for arthritis
2. Biotechnology industry expected to grow into a three billion dollar industry by 2002
3. Biotechnology on the lead
4. New Technology In MRI Scan Help Test Brain Cancer Therapy
5. New technology to decipher neural connections dealing with heredity and environment
6. Emergence Of New Gene Scanning Technology In Disease Research
7. CoQ10 bioavailability increased by Nanotechnology
8. Developing a new vaccine using a new technology
9. Scientists Develop New Technology To Find About Human Ancestors’ Teet
10. T-waves to sweep over imaging technology
11. Nanotechnology Revolution To Be Spearheaded By European Union
Post Your Comments:
(Date:11/27/2015)... Viejo, CA (PRWEB) , ... November 27, 2015 , ... ... for use in Final Cut Pro X. With ProSidebar: Fasion, video editors can ... or use ProSidebar as a minimalist title opener. Utilize presets featuring self-animating drop ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A simply groundbreaking ... is an interesting show that delves into an array of issues that are presently ... could benefit from open dialogue, this show is changing the subjects consumers focus on, ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... the largest, most successful and prominent nonprofit healthcare organizations in the country. They ... involvement with various organizations, and helped advance the healthcare industry as a whole ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point Recovery, ... together on Thanksgiving Day to share the things that they are most grateful ... Point YouTube channel, patients displayed what they wrote on index cards, describing the ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
Breaking Medicine Technology: